Dangerous Drugs

In June 2016, Acadia Pharmaceutical company released and distributed an atypical antipsyhoctic drug called Nuplazid which is manufactured to treat episodes of psychosis that those suffering from Parkinson’s disease is brought on by decreasing the severity and limitation of delusional episodes and hallucinations that disconnect the patient from reality. The FDA followed an expedited review…

Primus Pharmaceutical company has been warned by the Food and Drunk Administration to to pull the drug product, Limbrel, off the shelves due to the fact that it has been shown to cause lung and liver injury. Limbrel is marketed as a “medical food”, used to treat the metabolic processes linked with osteoarthritis. Primus stands…

Children who take prescription antipsychotics drugs, such as Zyprexa, are at a significantly higher risk of developing type 2 diabetes than youth who do not take antipsychotic medication…